Dr. Gorwit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1955 Citracado Pkwy
Ste 300
Escondido, CA 92029Phone+1 760-743-0546Fax+1 760-743-8837
Summary
- Dr. Jeffrey Gorwit is a cardiologist based in Escondido, CA, specializing in consultant general cardiology. He completed his fellowship in cardiovascular disease and residency in internal medicine at the University of California (San Diego) Medical Center. Dr. Gorwit has experience in general cardiology, valvular heart disease, cardiac catheterization, cardiac critical care, and minimally invasive cardiac surgery. He has contributed to several publications focusing on angina pectoris and hypertension. Additionally, he has received a CMS Meaningful Use Stage 1 Certification and is a Fellow of the American College of Cardiology.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1975 - 1976
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1972 - 1975
- State University of New York Downstate Medical Center College of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1973 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 4 citationsDuration of effects of isradipine during twice daily therapy in angina pectoris.Udho Thadani, Steven G. Chrysant, Jeffrey Gorwit, Thomas D. Giles, Stephen L. Archer
Cardiovascular Drugs and Therapy. 1994-04-01 - 44 citationsLack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrateUdho Thadani, Claude R. Maranda, Ezra A. Amsterdam, Leo J. Spaccavento, Richard G. Friedman
Annals of Internal Medicine. 1994-03-01 - 1 citationsA multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.James A. Schoenberger, J. D. Wallin, Jeffrey Gorwit, M. E. Davidov, Eric L. Michelson
American Journal of Hypertension. 1989-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: